A rare case of synchronous multiple primary lung cancer with different responses to gefitinib

Differentiating multiple primary lung cancer (MPLC) from lung metastasis is important, and the pathology and gene mutations may be different between the tumors. A lung biopsy to differentiate lesions should be considered, especially when the response of different tumors to treatment is distinct.

Guardado en:
Detalles Bibliográficos
Publicado en:Respir Med Case Rep
Autores principales: Liao, Che-Chi, Lin, Yu-Sen, Lin, Yu-Chao, Cheng, Chiao-Jen, Chen, Shuo-Chueh
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7596341/
https://ncbi.nlm.nih.gov/pubmed/33145160
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2020.101270
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares